fingolimod hydrochloride has been researched along with Drug Withdrawal Symptoms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braden, K; Chen, Z; Doyle, TM; Hutchinson, MR; Janes, K; Neumann, WL; Salvemini, D; Spiegel, S; Staikopoulos, V | 1 |
| Briner, M; Chan, A; Engelhardt, B; Evangelopoulos, ME; Hoepner, R; Huwiler, A; Miclea, A; Salmen, A; Schrewe, L | 1 |
| Adoni, T; Fragoso, YD; Gomes, S; Goncalves, MVM; Parolin, LF; Rosa, G; Ruocco, HH | 1 |
| Ayrignac, X; Cambron, M; Carra, C; Chouraki, A; Davion, JB; Duhin, E; Labauge, P; Lacour, A; Vermersch, P | 1 |
| Annovazzi, P; Baroncini, D; Comi, G; Filippi, M; Ghezzi, A; Minonzio, G; Rocca, MA; Zaffaroni, M | 1 |
1 review(s) available for fingolimod hydrochloride and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Severe Exacerbation of Multiple Sclerosis Following Withdrawal of Fingolimod.
Topics: Adult; Brazil; Disease Progression; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Retrospective Studies; Substance Withdrawal Syndrome | 2019 |
4 other study(ies) available for fingolimod hydrochloride and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents.
Topics: Analgesics, Opioid; Animals; Central Nervous System; Fingolimod Hydrochloride; Male; Mice; Mice, Inbred BALB C; Morphine; Naloxone; Narcotic Antagonists; Rodentia; Sphingosine-1-Phosphate Receptors; Substance Withdrawal Syndrome | 2020 |
Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod.
Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis; Recurrence; Retrospective Studies; Substance Withdrawal Syndrome | 2018 |
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
Topics: Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Recurrence; Substance Withdrawal Syndrome | 2016 |
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
Topics: Adult; Disability Evaluation; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Propylene Glycols; Recurrence; Sphingosine; Substance Withdrawal Syndrome | 2013 |